XML 33 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2013
Oct. 31, 2012
Cash flows from operating activities        
Net income $ 6,525 $ 5,749 $ 17,368 $ 13,099
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization 774 174 1,552 536
Amortization of premiums on short-term investments 98 23 276 23
Stock-based compensation 2,086 181 4,036 490
Deferred income taxes (86) (192) (259) (447)
Bad debt expense (303) 123 (21) 345
Changes in operating assets and liabilities:        
Accounts receivable (9,417) (7,196) (9,852) (8,849)
Income taxes (1,750) 2,541 (5,733) 3,379
Other current and non-current assets (1,224) (335) (2,117) (243)
Accounts payable 1,157 332 (946) 176
Accrued expenses 1,720 3,018 5,859 3,840
Deferred revenue 5,254 5,049 14,607 11,656
Long-term liabilities 433 249 758 (193)
Net cash provided by operating activities 5,267 9,716 25,528 23,812
Cash flows from investing activities        
Purchases of short-term investments (4,315) (9,888) (7,086) (9,888)
Maturities and sales of investments 2,250   4,850  
Purchases of property and equipment (460) (262) (1,561) (716)
Acquisitions, net of cash acquired     (12,149)  
Payments for capitalized internal-use software (720) (257) (1,013) (590)
Proceeds from (issuance of) note receivable-related party     253 (2)
Payments for restricted cash and deposits (5) (64) (2) (359)
Net cash used in investing activities (3,250) (10,471) (16,708) (11,555)
Cash flows from financing activities        
Proceeds from early exercise of common stock options 158 197 225 423
Proceeds from exercise of common stock options 95 37 472 78
Net proceeds from initial public offering 216,263   215,734  
Net cash provided by financing activities 216,516 234 216,431 501
Net change in cash and cash equivalents 218,533 (521) 225,251 12,758
Cash and cash equivalents at beginning of period 38,608 30,159 31,890 16,880
Cash and cash equivalents at end of period 257,141 29,638 257,141 29,638
Supplemental disclosures of other cash flow information:        
Cash paid for income taxes 4,998 669 14,984 4,058
Non-cash investing and financing activities:        
Property and equipment included in accounts payable and accrued expenses (46)    (20) 79
Vesting of early exercised stock options 212 55 460 179
Offering costs not yet paid $ 805    $ 1,473